Axon Enterprise logo
Axon Enterprise AXON
$ 491.65 -4.2%

Quarterly report 2026-Q1
added 05-16-2026

report update icon

Axon Enterprise Cash Conversion Cycle 2011-2026 | AXON

Annual Cash Conversion Cycle Axon Enterprise

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008
64.5 86.2 104 86.7 80.5 54.3 155 168 158 144 95.5 130 93.9 94.6 104 - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
168 54.3 108

Quarterly Cash Conversion Cycle Axon Enterprise

2026-Q1 2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
- - - 72 - - - - 100 106 97.5 - 36 68 67.6 - 78.2 86.8 86.4 - 88.1 113 61.4 - 23.4 25.3 30.7 - 43.3 47 68.9 - 83.1 98.9 91 - 86.9 103 79.7 - 39.8 48.1 58.4 - 62.1 69.5 50.7 - 55.9 83.7 62.3 - 82.7 90.2 84.6 - 44.1 50.7 -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
113 23.4 69.9

Cash Conversion Cycle of other stocks in the Biotechnology industry

Issuer Cash Conversion Cycle Price % 24h Market Cap Country
FSD Pharma FSD Pharma
HUGE
3.11 K - 5743.5 % $ 69.7 M canadaCanada
Happiness Biotech Group Limited Happiness Biotech Group Limited
HAPP
-3.12 K - 1.35 % $ 17.8 M chinaChina
AgeX Therapeutics AgeX Therapeutics
AGE
186 - -10.17 % $ 12.2 K usaUSA
Compugen Ltd. Compugen Ltd.
CGEN
-82.7 $ 2.13 -4.28 % $ 199 M israelIsrael
I-Mab I-Mab
IMAB
-1.97 K - - $ 866 M chinaChina
Coherus BioSciences Coherus BioSciences
CHRS
149 $ 1.49 -5.4 % $ 175 M usaUSA
Deciphera Pharmaceuticals Deciphera Pharmaceuticals
DCPH
-101 - - $ 2.18 B usaUSA
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
12.8 - - $ 40.3 B usaUSA
AstraZeneca PLC AstraZeneca PLC
AZN
-58 - - $ 96.9 B britainBritain
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
17 - -1.52 % $ 24.7 M usaUSA
Midatech Pharma plc Midatech Pharma plc
MTP
82.8 - -18.52 % $ 27.3 M britainBritain
CRISPR Therapeutics AG CRISPR Therapeutics AG
CRSP
1.1 K $ 52.65 -7.56 % $ 4.73 B schweizSchweiz
Affimed N.V. Affimed N.V.
AFMD
31.4 - -34.95 % $ 21.5 M germanyGermany
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
104 - - - russiaRussia
Celyad Oncology SA Celyad Oncology SA
CYAD
-55.7 K - - $ 12.5 M belgiumBelgium
Berkeley Lights Berkeley Lights
BLI
214 - -7.31 % $ 87 M usaUSA
Celldex Therapeutics Celldex Therapeutics
CLDX
-3.74 K $ 29.58 -1.17 % $ 1.96 B usaUSA
Generation Bio Co. Generation Bio Co.
GBIO
47.6 - - $ 344 M usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
-2.15 K - - $ 7.46 M israelIsrael
Cyclacel Pharmaceuticals Cyclacel Pharmaceuticals
CYCCP
-1.6 K - -4.36 % $ 27 M usaUSA
Anika Therapeutics Anika Therapeutics
ANIK
192 $ 14.69 -0.68 % $ 211 M usaUSA
Advaxis Advaxis
ADXS
-82.3 K - -9.65 % $ 45.9 M usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
-34.3 K - 5.93 % $ 314 M canadaCanada
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
126 - - $ 26.5 M usaUSA
AIkido Pharma AIkido Pharma
AIKI
-1.92 - 1.93 % $ 17.4 M usaUSA
Aptinyx Aptinyx
APTX
46.9 - -39.0 % $ 4.57 M usaUSA
Albireo Pharma Albireo Pharma
ALBO
-1.55 K - -0.23 % $ 916 M usaUSA
Arcutis Biotherapeutics Arcutis Biotherapeutics
ARQT
158 $ 22.06 0.5 % $ 2.81 B usaUSA
Ampio Pharmaceuticals Ampio Pharmaceuticals
AMPE
-4.62 K - -11.43 % $ 502 K usaUSA